# A Study to Evaluate the Pharmacokinetics of the CORT125134 Phase 2 Formulation in Healthy Male Subjects

> **NCT06094712** · PHASE1 · COMPLETED · sponsor: **Corcept Therapeutics** · enrollment: 8 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** CORT125134

## Key facts

- **NCT ID:** NCT06094712
- **Lead sponsor:** Corcept Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-07
- **Primary completion:** 2016-04-27
- **Final completion:** 2016-04-27
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2023-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06094712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06094712, "A Study to Evaluate the Pharmacokinetics of the CORT125134 Phase 2 Formulation in Healthy Male Subjects". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT06094712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*